home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

522 rows where has_cryoEM = 1, in_cev_map = 0 and tier = "Tier 1" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

surface_class 5

  • B_cargo 259
  • A_surface 164
  • A_assoc 45
  • unknown 40
  • A2_pm_peripheral 14

has_known_aptamer 2

  • 0 397
  • 1 125

tier 1

  • Tier 1 · 522 ✖

in_cev_map 1

  • - · 522 ✖

has_structure 1

  • 1 522

has_cryoEM 1

  • 1 · 522 ✖

has_activation_state_pdb_pair 1

  • 0 522
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P13569 CFTR Cystic fibrosis transmembrane conductance regulator Tier 1 0.824 1 A_surface 58 75.62 1 0     1 10 41148207, 31029337, 30595527, 22483890, 15657417 0 cystic fibrosis 0.9133535862571094
Q14654 KCNJ11 ATP-sensitive inward rectifier potassium channel 11 Tier 1 0.81 1 A_surface 9 83.81 1 0     0 0   0 type 2 diabetes mellitus 0.8651421397012851
P07949 RET Proto-oncogene tyrosine-protein kinase receptor Ret Tier 1 0.809 1 A_surface 34 78.81 1 0     1 83 41962371, 41744190, 41636718, 41526122, 41406741, 41171123, 41082837, 41060784, 41027166, 40932619, 40815127, 40711581, 40633058, 40602121, 40410423, 40285964, 40252505, 40222299, 39344894, 39288589, 39190775, 38953438, 38876068, 38852325, 38718747, 38604287, 38354543, 38282384, 38237282, 37851382, 37774402, 37757695, 37437453, 37245460, 36952259, 36315022, 35550937, 35420408, 34342436, 34132907, 34016094, 33513536, 33462661, 33119785, 33011620, 32760976, 32527800, 32212604, 32138930, 31897454 0 medullary thyroid gland carcinoma 0.8617460262224842
Q12809 KCNH2 Voltage-gated inwardly rectifying potassium channel KCNH2 Tier 1 0.806 1 A_surface 23 62.75 1 0     1 1 22617876 0 Romano-Ward syndrome 0.8549238933917284
P82251 SLC7A9 b(0,+)-type amino acid transporter 1 Tier 1 0.805 1 A_surface 4 85.44 1 0     0 0   0 cystinuria 0.8484952668941285
Q695T7 SLC6A19 Sodium-dependent neutral amino acid transporter B(0)AT1 Tier 1 0.804 1 A_surface 19 90.0 1 0     0 0   0 Hartnup disease 0.8464240093600148
P41180 CASR Extracellular calcium-sensing receptor Tier 1 0.804 1 A_surface 31 75.69 1 0     0 0   0 familial hypocalciuric hypercalcemia 1 0.8460848589627423
Q05586 GRIN1 Glutamate receptor ionotropic, NMDA 1 Tier 1 0.803 1 A_surface 84 82.88 1 0     0 0   0 neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant 0.8446685494288694
P07911 UMOD Uromodulin Tier 1 0.803 1 A_surface 10 82.94 1 0     1 4 37533140, 35446786 0 familial juvenile hyperuricemic nephropathy type 1 0.8446536377993564
O43526 KCNQ2 Potassium voltage-gated channel subfamily KQT member 2 Tier 1 0.803 1 A_surface 24 58.19 1 0     0 0   0 Benign familial neonatal seizures 0.8423358217314708
Q9HBA0 TRPV4 Transient receptor potential cation channel subfamily V member 4 Tier 1 0.801 1 A_surface 19 71.62 1 0     0 0   0 metatropic dysplasia 0.8356240344517467
P16473 TSHR Thyrotropin receptor Tier 1 0.8 1 A_surface 9 74.0 1 0     1 6 41054857, 40997970, 40588369, 38650837 0 hypothyroidism due to TSH receptor mutations 0.8327127196409464
Q92736 RYR2 Ryanodine receptor 2 Tier 1 0.8 1 A_surface 26   1 0     1 1 24130701 0 catecholaminergic polymorphic ventricular tachycardia 1 0.8338648743498255
Q8IZF0 NALCN Sodium leak channel NALCN Tier 1 0.796 1 A_surface 5 76.69 1 0     0 0   0 congenital contractures of the limbs and face, hypotonia, and developmental delay 0.8198033442161259
P41181 AQP2 Aquaporin-2 Tier 1 0.795 1 A_surface 7 91.75 1 0     0 0   0 diabetes insipidus, nephrogenic, autosomal 0.817870726313342
Q9ULV1 FZD4 Frizzled-4 Tier 1 0.795 1 A_surface 11 84.31 1 0     1 1 18673242 0 Familial exudative vitreoretinopathy 0.8152111103672746
Q13651 IL10RA Interleukin-10 receptor subunit alpha Tier 1 0.795 1 A_surface 7 62.0 1 0     1 2 25870409, 25558474 0 Autosomal recessive early-onset inflammatory bowel disease 0.8151052076044897
Q9H222 ABCG5 ATP-binding cassette sub-family G member 5 Tier 1 0.793 1 A_surface 8 85.06 1 0     0 0   0 sitosterolemia 0.810555184820483
Q9H1D0 TRPV6 Transient receptor potential cation channel subfamily V member 6 Tier 1 0.789 1 A_surface 24 80.56 1 0     0 0   0 hyperparathyroidism, transient neonatal 0.7964821997780153
Q14028 CNGB1 Cyclic nucleotide-gated channel beta-1 Tier 1 0.788 1 A_surface 11 57.66 1 0     0 0   0 retinitis pigmentosa 0.7931901344765326
P24530 EDNRB Endothelin receptor type B Tier 1 0.786 1 A_surface 17 75.0 1 0     0 0   0 Waardenburg syndrome type 4A 0.7874601728728147
Q03431 PTH1R Parathyroid hormone/parathyroid hormone-related peptide receptor Tier 1 0.786 1 A_surface 52 70.94 1 0     0 0   0 metaphyseal chondrodysplasia, Jansen type 0.7859378587442476
O60741 HCN1 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 Tier 1 0.786 1 A_surface 12 68.94 1 0     0 0   0 Generalized epilepsy with febrile seizures-plus 0.7853938745545654
O43909 EXTL3 Exostosin-like 3 Tier 1 0.785 1 A_surface 4 83.69 1 0     0 0   0 immunoskeletal dysplasia with neurodevelopmental abnormalities 0.7837827977649315
P22888 LHCGR Lutropin-choriogonadotropic hormone receptor Tier 1 0.785 1 A_surface 4 80.12 1 0     0 0   0 Leydig cell hypoplasia, type 1 0.783461117057047
P23416 GLRA2 Glycine receptor subunit alpha-2 Tier 1 0.784 1 A_surface 13 83.81 1 0     0 0   0 intellectual developmental disorder, X-linked, syndromic, Pilorge type 0.7805605973560554
P56696 KCNQ4 Potassium voltage-gated channel subfamily KQT member 4 Tier 1 0.783 1 A_surface 13 65.25 1 0     0 0   0 autosomal dominant nonsyndromic hearing loss 2A 0.7765455627642878
Q13224 GRIN2B Glutamate receptor ionotropic, NMDA 2B Tier 1 0.783 1 A_surface 36 60.69 1 0     0 0   0 intellectual disability, autosomal dominant 6 0.7771650025965382
P30531 SLC6A1 Sodium- and chloride-dependent GABA transporter 1 Tier 1 0.782 1 A_surface 5 87.94 1 0     0 0   0 epilepsy with myoclonic atonic seizures 0.7729414443362785
Q9NY46 SCN3A Sodium channel protein type 3 subunit alpha Tier 1 0.781 1 A_surface 2 68.25 1 0     0 0   0 familial focal epilepsy with variable foci 0.7708874082891223
P43220 GLP1R Glucagon-like peptide 1 receptor Tier 1 0.78 1 A_surface 70 81.5 1 0     1 2 40691365, 30957581 0 type 2 diabetes mellitus 0.7667004144705459
Q07699 SCN1B Sodium channel regulatory subunit beta-1 Tier 1 0.779 1 A_surface 36 87.06 1 0     0 0   0 Generalized epilepsy with febrile seizures-plus 0.7638796221342504
Q01668 CACNA1D Voltage-dependent L-type calcium channel subunit alpha-1D Tier 1 0.777 1 A_surface 6 64.31 1 0     0 0   0 aldosterone-producing adenoma with seizures and neurological abnormalities 0.7565859403082721
P30518 AVPR2 Vasopressin V2 receptor Tier 1 0.776 1 A_surface 38 76.0 1 0     0 0   0 nephrogenic syndrome of inappropriate antidiuresis 0.7522383646690638
O15399 GRIN2D Glutamate receptor ionotropic, NMDA 2D Tier 1 0.776 1 A_surface 13 63.22 1 0     0 0   0 developmental and epileptic encephalopathy, 46 0.7529662497608808
P48167 GLRB Glycine receptor subunit beta Tier 1 0.775 1 A_surface 12 78.06 1 0     0 0   0 hyperekplexia 2 0.7488854563756028
P08588 ADRB1 Beta-1 adrenergic receptor Tier 1 0.775 1 A_surface 7 75.31 1 0     0 0   0 hypertension 0.7498467911536156
P04035 HMGCR 3-hydroxy-3-methylglutaryl-coenzyme A reductase Tier 1 0.774 1 A_surface 24 75.31 1 0     1 1 36470581 0 Hypercholesterolemia 0.7460937406970991
P14416 DRD2 D(2) dopamine receptor Tier 1 0.774 1 A_surface 11 72.44 1 0     0 0   0 major depressive disorder 0.7450892965426774
P51681 CCR5 C-C chemokine receptor type 5 Tier 1 0.773 1 A_surface 25 85.38 1 0     1 23 36576612, 33981364, 29678881, 29556342, 29301363, 27807347, 27652575, 26965267, 25794434, 25754473, 25329893, 23629001, 22811524, 21576818, 18799178, 16631118, 16227301, 15813986, 14610191, 12498773 0 HIV infection 0.7442590579227027
P40259 CD79B B-cell antigen receptor complex-associated protein beta chain Tier 1 0.773 1 A_surface 5 75.38 1 0     0 0   0 diffuse large B-cell lymphoma 0.7442791518522275
P21860 ERBB3 Receptor tyrosine-protein kinase erbB-3 Tier 1 0.77 1 A_surface 23 72.44 1 0     1 9 40851486, 33770580, 33039492, 31846731, 31626948, 29440899, 23990977, 22733765, 18942860 0 visceral neuropathy, familial, 1, autosomal recessive 0.7335342096528644
Q8NET8 TRPV3 Transient receptor potential cation channel subfamily V member 3 Tier 1 0.769 1 A_surface 34 76.5 1 0     0 0   0 Olmsted syndrome 1 0.7314859339994324
Q9NPC2 KCNK9 Potassium channel subfamily K member 9 Tier 1 0.769 1 A_surface 22 75.94 1 0     0 0   0 Birk-Barel syndrome 0.73064701208734
P47871 GCGR Glucagon receptor Tier 1 0.766 1 A_surface 27 81.88 1 0     1 5 28775305, 23770039, 23744070 0 GCGR-related hyperglucagonemia 0.7213152740071143
P28223 HTR2A 5-hydroxytryptamine receptor 2A Tier 1 0.761 1 A_surface 38 73.75 1 0     0 0   0 major depressive disorder 0.703395899986692
P40225 THPO Thrombopoietin Tier 1 0.761 1 A_surface 3 61.44 1 0     1 2 38928037, 30312735 0 thrombocythemia 1 0.7027329039559379
Q9BYF1 ACE2 Angiotensin-converting enzyme 2 Tier 1 0.758 1 A_surface 100 90.69 1 0     1 91 41716474, 41541792, 41274248, 40642289, 40333723, 40321580, 40227272, 39964138, 39923730, 39281706, 38973558, 38553521, 37932762, 37808754, 37692001, 37666993, 37385465, 37375202, 36950312, 36822303, 36714461, 36683236, 36581924, 36073793, 35972202, 35910791, 35907639, 35542182, 34876524, 34855379, 34847324, 34798263, 34696413, 34619249, 34458322, 34282416, 34248841, 34230708, 34230707, 34166652, 34123223, 33684258, 33683787, 33629859, 33561300, 33389440, 32981365, 32838280, 32551560, 36288301, 36170362, 35748608, 34953639 0 COVID-19 0.6925739512122528
Q14973 SLC10A1 Hepatic sodium/bile acid cotransporter Tier 1 0.758 1 A_surface 11 83.5 1 0     0 0   0 hypercholanemia, familial, 2 0.6937781800382379
P48546 GIPR Gastric inhibitory polypeptide receptor Tier 1 0.758 1 A_surface 13 78.5 1 0     0 0   0 obesity 0.6926187130965883

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 587.644ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target